ELEFTHA 150mg Injection is a biologic therapy designed to treat moderate to severe autoimmune conditions, including rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. The active ingredient in ELEFTHA is Etanercept, a tumor necrosis factor (TNF)-alpha inhibitor. TNF-alpha is a protein that plays a key role in causing inflammation and joint damage in autoimmune diseases.

By blocking the activity of TNF-alpha, ELEFTHA reduces inflammation, alleviates pain, and helps prevent further joint damage. This treatment significantly improves joint mobility, reduces swelling, and enhances the overall quality of life for individuals suffering from chronic inflammatory conditions.

Key Benefits:

• Alleviates pain and swelling
• Reduces risk of joint damage and long-term disability
• Improves joint function and mobility
• Enhances quality of life for patients with chronic autoimmune conditions

Before starting treatment with ELEFTHA, patients should inform their healthcare provider about any infections or health conditions. Regular follow-ups and monitoring are essential to ensure safety and effectiveness during the course of therapy.

FAQs:

1. What is ELEFTHA 150mg Injection used for?

ELEFTHA 150mg Injection is used to treat moderate to severe autoimmune conditions, including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and other inflammatory diseases. It works by inhibiting TNF-alpha, a protein responsible for inflammation, thereby reducing symptoms such as pain, swelling, and preventing joint damage.

2. How does ELEFTHA 150mg Injection work?

ELEFTHA contains Etanercept, which is a TNF-alpha inhibitor. TNF-alpha is a protein that causes inflammation in autoimmune diseases. By blocking this protein, ELEFTHA helps reduce inflammation, alleviates pain, and prevents damage to joints and tissues.

3. How is ELEFTHA 150mg Injection administered?

ELEFTHA 150mg Injection is administered as a subcutaneous (under the skin) injection by a healthcare provider. The frequency of the injections is typically once a week or as prescribed by your doctor, based on the specific condition being treated.

4. Can ELEFTHA 150mg Injection cure autoimmune diseases?

ELEFTHA 150mg Injection does not cure autoimmune diseases. However, it helps manage symptoms, reduce inflammation, and prevent further joint damage, significantly improving the quality of life for people with chronic inflammatory conditions.

5. Can I take ELEFTHA 150mg Injection while pregnant or breastfeeding?

The safety of ELEFTHA during pregnancy or breastfeeding has not been fully established. It is important to consult your doctor before using this medication if you are pregnant, planning to conceive, or breastfeeding.

6. Can I drink alcohol while receiving ELEFTHA 150mg Injection?

It is recommended to limit alcohol consumption during treatment with ELEFTHA, as alcohol may increase the risk of side effects such as liver problems and interfere with your overall health. Always consult your doctor for specific advice regarding alcohol consumption.

7. How often do I need to receive ELEFTHA 150mg Injection?

ELEFTHA 150mg Injection is typically administered once a week. Your doctor will determine the exact dosage and schedule based on your condition and response to treatment. Regular follow-ups are necessary to ensure the treatment's effectiveness.